<DOC>
	<DOCNO>NCT01073020</DOCNO>
	<brief_summary>There substantial clinical evidence regard safety efficacy currently practice bariatric surgical technique improve metabolic control and/or resolve type 2 diabetes ( T2DM ) clinically severe obese patient ( class 3 obesity ) . Evidence suggest procedure great effect insulin secretion insulin action expect weight loss alone , lead recent claim procedure may useful primary treatment T2DM moderately obese population . Concurrently , also substantial advance non-surgical medical management T2DM . As result , best treatment algorithm T2DM patient class 1 &amp; 2 obesity increasingly controversial . This trial investigate utility currently practice available bariatric surgical procedure compare multidisciplinary intensive medical weight management treatment T2DM class 1 2 obesity .</brief_summary>
	<brief_title>Surgery Lifestyle With Intensive Medical Management Treatment Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Potential participant T2DM , diagnosis diabetes least one year duration , BMI 3045 kg/m2 LAGB compare intensive medical weight diabetes management BMI 3042 kg/m2 LRYGB compare intensive medical weight diabetes management , Age 2165 year , With strong desire substantial weight loss , free active cardiovascular disease would render unable partake structured exercise program undergo bariatric surgical procedure , committed life long medical nutritional follow . Detectable level GAD antibody history diabetic ketoacidosis uncontrolled T2DM ( consistent fast blood glucose &gt; 200 mg/dl HbA1c twice normal ) ; Previous gastrointestinal surgery , inflammatory bowel disease , esophageal disease include severe intractable esophagitis , Barrett 's Disease , esophageal dysmotility impair gastric motility ( gastroparesis ) , hiatal hernia &gt; 3 cm size , chronic acute bleed condition include peptic ulcer disease , portal hypertension ( gastric esophageal varix ) , chronic pancreatitis , cirrhosis liver ; Malignant debilitate medical condition , severe cardiopulmonary disease include uncontrolled hypertension ( repeat systolic measure &gt; 160 diastolic &gt; 95 mm Hg one day ) , unstable angina pectoris , recent myocardial infarction within 6 month , history coronary artery bypass surgery angioplasty , congestive heart failure , arrhythmia , stroke transient ischemic attack , urinary albumin excretion &gt; 300 mcg/mg creatinine and/or serum creatinine &gt; 1.5 mg/dL ( permit safety increase dietary protein intake ) , Any endocrine disorder T2DM thyroid disease stable replacement therapy , include Cushing 's syndrome ; Any previous history eat disorder , history drug and/or alcohol abuse within 2 year screen visit , history impair mental status DSMIV ( Diagnostic Statistical Manual , 4th Edition ) criterion include , limit active substance abuse , history schizophrenia , borderline personality disorder , uncontrolled depression , suicidal attempt within past two year current suicidal tendency ideation . Subjects exclude history significant weight loss ( &gt; 3 % ) within previous 3 month participation alternate medically supervise exercise weight reduction program within previous 3 month , use prescription counter weight reduction medication supplement within one month Screening Visit duration study participation . Women lactate , plan pregnancy , unwilling use contraception course trial .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Type 2 Diabetes Mellitus</keyword>
	<keyword>Obesity</keyword>
	<keyword>Lifestyle</keyword>
	<keyword>Bariatric Surgery</keyword>
	<keyword>Laparoscopic Adjustable Gastric Band</keyword>
	<keyword>Laparoscopic Roux-en-Y Gastric Bypass</keyword>
</DOC>